IL240949B
An aqueous pharmaceutical formulation for use in the treatment of type 1 or 2 diabetes mellitus
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
48 members in 22 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 13305432 | European Patent Office (EPO) | A | |
| 13290188 | European Patent Office (EPO) | A | |
| 13306412 | European Patent Office (EPO) | A | |
| 2014056498 | European Patent Office (EPO) | W |
Members48
| Document | Office | Kind | |
|---|---|---|---|
| CA2907848A1 | Canada | A1 | |
| WO2014161837A1 | World Intellectual Property Organization (WIPO) | A1 | |
| SG11201506888VA | Singapore | A | |
| AU2014247167A1 | Australia | A1 | |
| IL240949A0 | Israel | A0 | |
| CN105142661A | China | A | |
| KR20150138262A | Republic of Korea | A | |
| PH12015501931A1 | Philippines | A1 | |
| PH12015501931B1 | Philippines | B1 | |
| US2016030339A1 | United States of America | A1 | |
| EP2983697A1 | European Patent Office (EPO) | A1 | |
| CL2015002914A1 | Chile | A1 | |
| JP2016519100A | Japan | A | |
| MX2015014007A | Mexico | A | |
| ZA201506420B | South Africa | B | |
| HK1214520A | Hong Kong, China | A | |
| HK1214520A1 | Hong Kong, China | A1 | |
| RU2015146982A | Russian Federation | A | |
| BR112015024659A2 | Brazil | A2 | |
| UA117480C2 | Ukraine | C2 | |
| US10092513B2 | United States of America | B2 | |
| EP2983697B1 | European Patent Office (EPO) | B1 | |
| AU2014247167B2 | Australia | B2 | |
| JP6457484B2 | Japan | B2 | |
| DK2983697T3 | Denmark | T3 | |
| US2019060233A1 | United States of America | A1 | |
| ES2709339T3 | Spain | T3 | |
| IL240949A | Israel | A | |
| IL240949BThis record | Israel | B | |
| HUE042381T2 | Hungary | T2 | |
| EP3517122A1 | European Patent Office (EPO) | A1 | |
| CN105142661B | China | B | |
| CN110354255A | China | A | |
| MX369511B | Mexico | B | |
| RU2705797C2 | Russian Federation | C2 | |
| BR112015024659A8 | Brazil | A8 | |
| US2020136825A1 | United States of America | A1 | |
| RU2019133674A | Russian Federation | A | |
| US2020170945A1 | United States of America | A1 | |
| US10785029B2 | United States of America | B2 | |
| KR102180215B1 | Republic of Korea | B1 | |
| KR20200130511A | Republic of Korea | A | |
| MY181626A | Malaysia | A | |
| US11191722B2 | United States of America | B2 | |
| US2022202711A1 | United States of America | A1 | |
| CN110354255B | China | B | |
| EP4613284A2 | European Patent Office (EPO) | A2 | |
| EP4613284A3 | European Patent Office (EPO) | A3 |
3 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF | |
| Patent renewedKB | KB |
Numbers
- Publication
- 240949
- Application
- 240949
Titles2
- English
- An aqueous pharmaceutical formulation for use in the treatment of type 1 or 2 diabetes mellitus
- Hebrew
- פורמולציה רוקחית מימית לשימוש בטיפול בסכרת נעורים סוג 1 או סוג 2
Classification
- CPC, 9
- A61K38/28
- A61K9/08
- A61K31/155
- A61K9/0019
- A61P3/10
- A61K38/26
- A61K47/02
- A61K47/10
- A61K47/26